Benjamin J. Turk, BA

Although the prevalence of coronary heart disease and death from acute myocardial infarction (AMI) have declined steadily, about 935,000 heart attacks still occur annually in the United States, with approximately one‐third of these being fatal.[1, 2, 3] Studies have demonstrated decreased 30‐day and longer‐term mortality in AMI patients who receive evidence‐based treatment, including aspirin, ‐blockers, angiotensin‐converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs), anticoagulation therapy, and statins.[4, 5, 6, 7] Despite clinical practice guidelines (CPGs) outlining evidence‐based care and considerable efforts to implement processes that improve patient outcomes, delivery of effective therapy remains suboptimal.[8] For example, the Hospital Quality Alliance Program[9] found that in AMI patients, use of aspirin on admission was only 81% to 92%, ‐blocker on admission 75% to 85%, and ACE inhibitors for left ventricular dysfunction 71% to 74%.

Efforts to increase adherence to CPGs and improve patient outcomes in AMI have resulted in variable degrees of success. They include promotion of CPGs,[4, 5, 6, 7] physician education with feedback, report cards, care paths, registries,[10] Joint Commission standardized measures,[11] and paper checklists or order sets (OS).[12, 13]

In this report, we describe the association between use of an evidence‐based, electronic OS for AMI (AMI‐OS) and better adherence to CPGs. This AMI‐OS was implemented in the inpatient electronic medical records (EMRs) of a large integrated healthcare delivery system, Kaiser Permanente Northern California (KPNC). The purpose of our investigation was to determine (1) whether use of the AMI‐OS was associated with improved AMI processes and patient outcomes, and (2) whether these associations persisted after risk adjustment using a comprehensive severity of illness scoring system.

MATERIALS AND METHODS

This project was approved by the KPNC institutional review board.

Under a mutual exclusivity arrangement, salaried physicians of The Permanente Medical Group, Inc., care for 3.4 million Kaiser Foundation Health Plan, Inc. members at facilities owned by Kaiser Foundation Hospitals, Inc. All KPNC facilities employ the same information systems with a common medical record number and can track care covered by the plan but delivered elsewhere.[14] Our setting consisted of 21 KPNC hospitals described in previous reports,[15, 16, 17, 18] using the same commercially available EMR system that includes computerized physician order entry (CPOE). Deployment of the customized inpatient Epic EMR (www.epicsystems.com), known internally as KP HealthConnect (KPHC), began in 2006 and was completed in 2010.

In this EMR's CPOE, physicians have options to select individual orders (a la carte) or they can utilize an OS, which is a collection of the most appropriate orders associated with specific diagnoses, procedures, or treatments. The evidence‐based AMI‐OS studied in this project was developed by a multidisciplinary team (for detailed components see Supporting Appendix 1Appendix 5 in the online version of this article).

Our study focused on the first set of hospital admission orders for patients with AMI. The study sample consisted of patients meeting these criteria: (1) age 18 years at admission; (2) admitted to a KPNC hospital for an overnight stay between September 28, 2008 and December 31, 2010; (3) principal diagnosis was AMI (International Classification of Diseases, 9th Revision [ICD‐9][19] codes 410.00, 01, 10, 11, 20, 21, 30, 31, 40, 41, 50, 51, 60, 61, 70, 71, 80, 90, and 91); and (4) KPHC had been operational at the hospital for at least 3 months to be included (for assembly descriptions see Supporting Appendices 15 in the online version of this article). At the study hospitals, troponin I was measured using the Beckman Access AccuTnI assay (Beckman Coulter, Inc., Brea, CA), whose upper reference limit (99th percentile) is 0.04 ng/mL. We excluded patients initially hospitalized for AMI at a non‐KPNC site and transferred into a study hospital.

The data processing methods we employed have been detailed elsewhere.[14, 15, 17, 20, 21, 22] The dependent outcome variables were total hospital length of stay, inpatient mortality, 30‐day mortality, and all‐cause rehospitalization within 30 days of discharge. Linked state mortality data were unavailable for the entire study period, so we ascertained 30‐day mortality based on the combination of KPNC patient demographic data and publicly available Social Security Administration decedent files. We ascertained rehospitalization by scanning KPNC hospitalization databases, which also track out‐of‐plan use.

The dependent process variables were use of aspirin within 24 hours of admission, ‐blockers, anticoagulation, ACE inhibitors or ARBs, and statins. The primary independent variable of interest was whether or not the admitting physician employed the AMI‐OS when admission orders were entered. Consequently, this variable is dichotomous (AMI‐OS vs a la carte).

We controlled for acute illness severity and chronic illness burden using a recent modification[22] of an externally validated risk‐adjustment system applicable to all hospitalized patients.[15, 16, 23, 24, 25] Our methodology included vital signs, neurological status checks, and laboratory test results obtained in the 72 hours preceding hospital admission; comorbidities were captured longitudinally using data from the year preceding hospitalization (for comparison purposes, we also assigned a Charlson Comorbidity Index score[26]).

End‐of‐life care directives are mandatory on admission at KPNC hospitals. Physicians have 4 options: full code, partial code, do not resuscitate, and comfort care only. Because of small numbers in some categories, we collapsed these 4 categories into full code and not full code. Because patients' care directives may change, we elected to capture the care directive in effect when a patient first entered a hospital unit other than the emergency department (ED).

Two authors (M.B., P.C.L.), one of whom is a board‐certified cardiologist, reviewed all admission electrocardiograms and made a consensus determination as to whether or not criteria for ST‐segment elevation myocardial infarction (STEMI) were present (ie, new ST‐segment elevation or left bundle branch block); we also reviewed the records of all patients with missing troponin I data to confirm the AMI diagnosis.

RESULTS

Table 1 summarizes the characteristics of the 5879 patients. It shows that AMI‐OS patients were more likely to receive evidence‐based therapies for AMI (aspirin, ‐blockers, ACE inhibitors or ARBs, anticoagulation, and statins) and had a 46% lower mortality rate in hospital (3.51 % vs 6.52%) and 33% lower rate at 30 days (5.66% vs 8.48%). AMI‐OS patients were also found to be at lower risk for an adverse outcome than nonAMI‐OS patients. The AMI‐OS patients had lower peak troponin I values, severity of illness (lower Laboratory‐Based Acute Physiology Score, version 2 [LAPS2] scores), comorbidity burdens (lower Comorbidity Point Score, version 2 [COPS2] and Charlson scores), and global predicted mortality risk. AMI‐OS patients were also less likely to have required intensive care. AMI‐OS patients were at higher risk of death than nonAMI‐OS patients with respect to only 1 variable (being full code at the time of admission), but although this difference was statistically significant, it was of minor clinical impact (86% vs 88%).

Table 2 shows the result of a logistic regression model in which the dependent variable was inpatient mortality and either the 5 evidence‐based therapies or the total number of evidence‐based therapies are the dependent variables. ‐blocker, statin, and ACE inhibitor or ARB therapies all had a protective effect on mortality, with odds ratios ranging from 0.48 (95% confidence interval [CI]: 0.36‐0.64), 0.63 (95% CI: 0.45‐0.89), and 0.40 (95% CI: 0.30‐0.53), respectively. An increased number of therapies also had a beneficial effect on inpatient mortality, with patients having 3 or more of the evidence‐based therapies showing an adjusted odds ratio (AOR) of 0.49 (95% CI: 0.33‐0.73), 4 or more therapies an AOR of 0.29 (95% CI: 0.20‐0.42), and 0.17 (95% CI: 0.11‐0.25) for 5 or more therapies.

Table 3 shows that the use of the AMI‐OS is protective, with an AOR of 0.59 and a 95% CI of 0.45‐0.76. Table 3 also shows that the most potent predictors were comorbidity burden (AOR: 1.07, 95% CI: 1.03‐1.10 per 10 COPS2 points), severity of illness (AOR: 1.09, 95% CI: 1.07‐1.12 per 10 LAPS2 points), STEMI (AOR: 3.86, 95% CI: 2.68‐5.58), and timing of cardiac catheterization referral occurring immediately prior to or during the admission (AOR: 0.37, 95% CI: 0.27‐0.51). The statistical significance of the AMI‐OS effect disappears when both AMI‐OS and the individual therapies are included in the same model (see Supporting Information, Appendices 15, in the online version of this article).

Table 4 shows separately the average treatment effect (ATE) and average treatment effect for the treated (ATT) of AMI‐OS and of increasing number of therapies on other outcomes (30‐day mortality, LOS, and readmission). Both the ATE and ATT show that the use of the AMI‐OS was significantly protective with respect to mortality and total hospital LOS but not significant with respect to readmission. The effect of the number of therapies on mortality is significantly higher with increasing number of therapies. For example, patients who received 5 therapies had an average treatment effect on 30‐day inpatient mortality of 0.23 (95% CI: 0.15‐0.35) compared to 0.64 (95% CI: 0.43‐0.96) for 3 therapies, almost a 3‐fold difference. The effects of increasing number of therapies were not significant for LOS or readmission. A sensitivity analysis in which the 535 STEMI patients were removed showed essentially the same results, so it is not reported here.

To further elucidate possible reasons why physicians did not use the AMI‐OS, the lead author reviewed 105 randomly selected records where the AMI‐OS was not used, 5 records from each of the 21 study hospitals. This review found that in 36% of patients, the AMI‐OS was not used because emergent catheterization or transfer to a facility with percutaneous coronary intervention capability occurred. Presence of other significant medical conditions, including critical illness, was the reason in 17% of these cases, patient or family refusal of treatments in 8%, issues around end‐of‐life care in 3%, and specific medical contraindications in 1%. In the remaining 34%, no reason for not using the AMI‐OS could be identified.

DISCUSSION

We evaluated the use of an evidence‐based electronic AMI‐OS embedded in a comprehensive EMR and found that it was beneficial. Its use was associated with increased adherence to evidence‐based therapies, which in turn were associated with improved outcomes. Using data from a large cohort of hospitalized AMI patients in 21 community hospitals, we were able to use risk adjustment that included physiologic illness severity to adjust for baseline mortality risk. Patients in whom the AMI‐OS was employed tended to be at lower risk; nonetheless, after controlling for confounding variables and adjusting for bias using propensity scores, the AMI‐OS was associated with increased use of evidence‐based therapies and decreased mortality. Most importantly, it appears that the benefits of the OS were not just due to increased receipt of individual recommended therapies, but to increased concurrent receipt of multiple recommended therapies.

Modern EMRs have great potential for significant improvements in the quality, efficiency, and safety of care provided,[36] and our study highlights this potential. However, a number of important limitations to our study must be considered. Although we had access to a very rich dataset, we could not control for all possible confounders, and our risk adjustment cannot match the level of information available to clinicians. In particular, the measurements available to us with respect to cardiac risk are limited. Thus, we have to recognize that the strength of our findings does not approximate that of a randomized trial, and one would expect that the magnitude of the beneficial association would fall under more controlled conditions. Resource limitations also did not permit us to gather more time course data (eg, sequential measurements of patient instability, cardiac damage, or use of recommended therapies), which could provide a better delineation of differences in both processes and outcomes.

Limitations also exist to the generalizability of the use of order sets in other settings that go beyond the availability of a comprehensive EMR. Our study population was cared for in a setting with an unusually high level of integration.[1] For example, KPNC has an elaborate administrative infrastructure for training in the use of the EMR as well as ensuring that order sets are not just evidence‐based, but that they are perceived by clinicians to be of significant value. This infrastructure, established to ensure physician buy‐in, may not be easy to replicate in smaller or less‐integrated settings. Thus, it is conceivable that factors other than the degree of support during the EMR deployments can affect rates of order set use.

Although our use of counterfactual methods included illness severity (LAPS2) and longitudinal comorbidity burden (COPS2), which are not yet available outside highly integrated delivery services employing comprehensive EMRs, it is possible they are insufficient. We cannot exclude the possibility that other biases or patient characteristics were present that led clinicians to preferentially employ the electronic order set in some patients but not in others. One could also argue that future studies should consider using overall adherence to recommended AMI treatment guidelines as a risk adjustment tool that would permit one to analyze what other factors may be playing a role in residual differences in patient outcomes. Last, one could object to our inclusion of STEMI patients; however, this was not a study on optimum treatment strategies for STEMI patients. Rather, it was a study on the impact on AMI outcomes of a specific component of computerized order entry outside the research setting.

Despite these limitations, we believe that our findings provide strong support for the continued use of electronic evidence‐based order sets in the inpatient medical setting. Once the initial implementation of a comprehensive EMR has occurred, deployment of these electronic order sets is a relatively inexpensive but effective method to foster compliance with evidence‐based care.

Future research in healthcare information technology can take a number of directions. One important area, of course, revolves around ways to promote enhanced physician adoption of EMRs. Our audit of records where the AMI‐OS was not used found that specific reasons for not using the order set (eg, treatment refusals, emergent intervention) were present in two‐thirds of the cases. This suggests that future analyses of adherence involving EMRs and CPOE implementation should take a more nuanced look at how order entry is actually enabled. It may be that understanding how order sets affect care enhances clinician acceptance and thus could serve as an incentive to EMR adoption. However, once an EMR is adopted, a need exists to continue evaluations such as this because, ultimately, the gold standard should be improved patient care processes and better outcomes for patients.

Although the prevalence of coronary heart disease and death from acute myocardial infarction (AMI) have declined steadily, about 935,000 heart attacks still occur annually in the United States, with approximately one‐third of these being fatal.[1, 2, 3] Studies have demonstrated decreased 30‐day and longer‐term mortality in AMI patients who receive evidence‐based treatment, including aspirin, ‐blockers, angiotensin‐converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs), anticoagulation therapy, and statins.[4, 5, 6, 7] Despite clinical practice guidelines (CPGs) outlining evidence‐based care and considerable efforts to implement processes that improve patient outcomes, delivery of effective therapy remains suboptimal.[8] For example, the Hospital Quality Alliance Program[9] found that in AMI patients, use of aspirin on admission was only 81% to 92%, ‐blocker on admission 75% to 85%, and ACE inhibitors for left ventricular dysfunction 71% to 74%.

Efforts to increase adherence to CPGs and improve patient outcomes in AMI have resulted in variable degrees of success. They include promotion of CPGs,[4, 5, 6, 7] physician education with feedback, report cards, care paths, registries,[10] Joint Commission standardized measures,[11] and paper checklists or order sets (OS).[12, 13]

In this report, we describe the association between use of an evidence‐based, electronic OS for AMI (AMI‐OS) and better adherence to CPGs. This AMI‐OS was implemented in the inpatient electronic medical records (EMRs) of a large integrated healthcare delivery system, Kaiser Permanente Northern California (KPNC). The purpose of our investigation was to determine (1) whether use of the AMI‐OS was associated with improved AMI processes and patient outcomes, and (2) whether these associations persisted after risk adjustment using a comprehensive severity of illness scoring system.

MATERIALS AND METHODS

This project was approved by the KPNC institutional review board.

Under a mutual exclusivity arrangement, salaried physicians of The Permanente Medical Group, Inc., care for 3.4 million Kaiser Foundation Health Plan, Inc. members at facilities owned by Kaiser Foundation Hospitals, Inc. All KPNC facilities employ the same information systems with a common medical record number and can track care covered by the plan but delivered elsewhere.[14] Our setting consisted of 21 KPNC hospitals described in previous reports,[15, 16, 17, 18] using the same commercially available EMR system that includes computerized physician order entry (CPOE). Deployment of the customized inpatient Epic EMR (www.epicsystems.com), known internally as KP HealthConnect (KPHC), began in 2006 and was completed in 2010.

In this EMR's CPOE, physicians have options to select individual orders (a la carte) or they can utilize an OS, which is a collection of the most appropriate orders associated with specific diagnoses, procedures, or treatments. The evidence‐based AMI‐OS studied in this project was developed by a multidisciplinary team (for detailed components see Supporting Appendix 1Appendix 5 in the online version of this article).

Our study focused on the first set of hospital admission orders for patients with AMI. The study sample consisted of patients meeting these criteria: (1) age 18 years at admission; (2) admitted to a KPNC hospital for an overnight stay between September 28, 2008 and December 31, 2010; (3) principal diagnosis was AMI (International Classification of Diseases, 9th Revision [ICD‐9][19] codes 410.00, 01, 10, 11, 20, 21, 30, 31, 40, 41, 50, 51, 60, 61, 70, 71, 80, 90, and 91); and (4) KPHC had been operational at the hospital for at least 3 months to be included (for assembly descriptions see Supporting Appendices 15 in the online version of this article). At the study hospitals, troponin I was measured using the Beckman Access AccuTnI assay (Beckman Coulter, Inc., Brea, CA), whose upper reference limit (99th percentile) is 0.04 ng/mL. We excluded patients initially hospitalized for AMI at a non‐KPNC site and transferred into a study hospital.

The data processing methods we employed have been detailed elsewhere.[14, 15, 17, 20, 21, 22] The dependent outcome variables were total hospital length of stay, inpatient mortality, 30‐day mortality, and all‐cause rehospitalization within 30 days of discharge. Linked state mortality data were unavailable for the entire study period, so we ascertained 30‐day mortality based on the combination of KPNC patient demographic data and publicly available Social Security Administration decedent files. We ascertained rehospitalization by scanning KPNC hospitalization databases, which also track out‐of‐plan use.

The dependent process variables were use of aspirin within 24 hours of admission, ‐blockers, anticoagulation, ACE inhibitors or ARBs, and statins. The primary independent variable of interest was whether or not the admitting physician employed the AMI‐OS when admission orders were entered. Consequently, this variable is dichotomous (AMI‐OS vs a la carte).

We controlled for acute illness severity and chronic illness burden using a recent modification[22] of an externally validated risk‐adjustment system applicable to all hospitalized patients.[15, 16, 23, 24, 25] Our methodology included vital signs, neurological status checks, and laboratory test results obtained in the 72 hours preceding hospital admission; comorbidities were captured longitudinally using data from the year preceding hospitalization (for comparison purposes, we also assigned a Charlson Comorbidity Index score[26]).

End‐of‐life care directives are mandatory on admission at KPNC hospitals. Physicians have 4 options: full code, partial code, do not resuscitate, and comfort care only. Because of small numbers in some categories, we collapsed these 4 categories into full code and not full code. Because patients' care directives may change, we elected to capture the care directive in effect when a patient first entered a hospital unit other than the emergency department (ED).

Two authors (M.B., P.C.L.), one of whom is a board‐certified cardiologist, reviewed all admission electrocardiograms and made a consensus determination as to whether or not criteria for ST‐segment elevation myocardial infarction (STEMI) were present (ie, new ST‐segment elevation or left bundle branch block); we also reviewed the records of all patients with missing troponin I data to confirm the AMI diagnosis.

RESULTS

Table 1 summarizes the characteristics of the 5879 patients. It shows that AMI‐OS patients were more likely to receive evidence‐based therapies for AMI (aspirin, ‐blockers, ACE inhibitors or ARBs, anticoagulation, and statins) and had a 46% lower mortality rate in hospital (3.51 % vs 6.52%) and 33% lower rate at 30 days (5.66% vs 8.48%). AMI‐OS patients were also found to be at lower risk for an adverse outcome than nonAMI‐OS patients. The AMI‐OS patients had lower peak troponin I values, severity of illness (lower Laboratory‐Based Acute Physiology Score, version 2 [LAPS2] scores), comorbidity burdens (lower Comorbidity Point Score, version 2 [COPS2] and Charlson scores), and global predicted mortality risk. AMI‐OS patients were also less likely to have required intensive care. AMI‐OS patients were at higher risk of death than nonAMI‐OS patients with respect to only 1 variable (being full code at the time of admission), but although this difference was statistically significant, it was of minor clinical impact (86% vs 88%).

Table 2 shows the result of a logistic regression model in which the dependent variable was inpatient mortality and either the 5 evidence‐based therapies or the total number of evidence‐based therapies are the dependent variables. ‐blocker, statin, and ACE inhibitor or ARB therapies all had a protective effect on mortality, with odds ratios ranging from 0.48 (95% confidence interval [CI]: 0.36‐0.64), 0.63 (95% CI: 0.45‐0.89), and 0.40 (95% CI: 0.30‐0.53), respectively. An increased number of therapies also had a beneficial effect on inpatient mortality, with patients having 3 or more of the evidence‐based therapies showing an adjusted odds ratio (AOR) of 0.49 (95% CI: 0.33‐0.73), 4 or more therapies an AOR of 0.29 (95% CI: 0.20‐0.42), and 0.17 (95% CI: 0.11‐0.25) for 5 or more therapies.

Table 3 shows that the use of the AMI‐OS is protective, with an AOR of 0.59 and a 95% CI of 0.45‐0.76. Table 3 also shows that the most potent predictors were comorbidity burden (AOR: 1.07, 95% CI: 1.03‐1.10 per 10 COPS2 points), severity of illness (AOR: 1.09, 95% CI: 1.07‐1.12 per 10 LAPS2 points), STEMI (AOR: 3.86, 95% CI: 2.68‐5.58), and timing of cardiac catheterization referral occurring immediately prior to or during the admission (AOR: 0.37, 95% CI: 0.27‐0.51). The statistical significance of the AMI‐OS effect disappears when both AMI‐OS and the individual therapies are included in the same model (see Supporting Information, Appendices 15, in the online version of this article).

Table 4 shows separately the average treatment effect (ATE) and average treatment effect for the treated (ATT) of AMI‐OS and of increasing number of therapies on other outcomes (30‐day mortality, LOS, and readmission). Both the ATE and ATT show that the use of the AMI‐OS was significantly protective with respect to mortality and total hospital LOS but not significant with respect to readmission. The effect of the number of therapies on mortality is significantly higher with increasing number of therapies. For example, patients who received 5 therapies had an average treatment effect on 30‐day inpatient mortality of 0.23 (95% CI: 0.15‐0.35) compared to 0.64 (95% CI: 0.43‐0.96) for 3 therapies, almost a 3‐fold difference. The effects of increasing number of therapies were not significant for LOS or readmission. A sensitivity analysis in which the 535 STEMI patients were removed showed essentially the same results, so it is not reported here.

To further elucidate possible reasons why physicians did not use the AMI‐OS, the lead author reviewed 105 randomly selected records where the AMI‐OS was not used, 5 records from each of the 21 study hospitals. This review found that in 36% of patients, the AMI‐OS was not used because emergent catheterization or transfer to a facility with percutaneous coronary intervention capability occurred. Presence of other significant medical conditions, including critical illness, was the reason in 17% of these cases, patient or family refusal of treatments in 8%, issues around end‐of‐life care in 3%, and specific medical contraindications in 1%. In the remaining 34%, no reason for not using the AMI‐OS could be identified.

DISCUSSION

We evaluated the use of an evidence‐based electronic AMI‐OS embedded in a comprehensive EMR and found that it was beneficial. Its use was associated with increased adherence to evidence‐based therapies, which in turn were associated with improved outcomes. Using data from a large cohort of hospitalized AMI patients in 21 community hospitals, we were able to use risk adjustment that included physiologic illness severity to adjust for baseline mortality risk. Patients in whom the AMI‐OS was employed tended to be at lower risk; nonetheless, after controlling for confounding variables and adjusting for bias using propensity scores, the AMI‐OS was associated with increased use of evidence‐based therapies and decreased mortality. Most importantly, it appears that the benefits of the OS were not just due to increased receipt of individual recommended therapies, but to increased concurrent receipt of multiple recommended therapies.

Modern EMRs have great potential for significant improvements in the quality, efficiency, and safety of care provided,[36] and our study highlights this potential. However, a number of important limitations to our study must be considered. Although we had access to a very rich dataset, we could not control for all possible confounders, and our risk adjustment cannot match the level of information available to clinicians. In particular, the measurements available to us with respect to cardiac risk are limited. Thus, we have to recognize that the strength of our findings does not approximate that of a randomized trial, and one would expect that the magnitude of the beneficial association would fall under more controlled conditions. Resource limitations also did not permit us to gather more time course data (eg, sequential measurements of patient instability, cardiac damage, or use of recommended therapies), which could provide a better delineation of differences in both processes and outcomes.

Limitations also exist to the generalizability of the use of order sets in other settings that go beyond the availability of a comprehensive EMR. Our study population was cared for in a setting with an unusually high level of integration.[1] For example, KPNC has an elaborate administrative infrastructure for training in the use of the EMR as well as ensuring that order sets are not just evidence‐based, but that they are perceived by clinicians to be of significant value. This infrastructure, established to ensure physician buy‐in, may not be easy to replicate in smaller or less‐integrated settings. Thus, it is conceivable that factors other than the degree of support during the EMR deployments can affect rates of order set use.

Although our use of counterfactual methods included illness severity (LAPS2) and longitudinal comorbidity burden (COPS2), which are not yet available outside highly integrated delivery services employing comprehensive EMRs, it is possible they are insufficient. We cannot exclude the possibility that other biases or patient characteristics were present that led clinicians to preferentially employ the electronic order set in some patients but not in others. One could also argue that future studies should consider using overall adherence to recommended AMI treatment guidelines as a risk adjustment tool that would permit one to analyze what other factors may be playing a role in residual differences in patient outcomes. Last, one could object to our inclusion of STEMI patients; however, this was not a study on optimum treatment strategies for STEMI patients. Rather, it was a study on the impact on AMI outcomes of a specific component of computerized order entry outside the research setting.

Despite these limitations, we believe that our findings provide strong support for the continued use of electronic evidence‐based order sets in the inpatient medical setting. Once the initial implementation of a comprehensive EMR has occurred, deployment of these electronic order sets is a relatively inexpensive but effective method to foster compliance with evidence‐based care.

Future research in healthcare information technology can take a number of directions. One important area, of course, revolves around ways to promote enhanced physician adoption of EMRs. Our audit of records where the AMI‐OS was not used found that specific reasons for not using the order set (eg, treatment refusals, emergent intervention) were present in two‐thirds of the cases. This suggests that future analyses of adherence involving EMRs and CPOE implementation should take a more nuanced look at how order entry is actually enabled. It may be that understanding how order sets affect care enhances clinician acceptance and thus could serve as an incentive to EMR adoption. However, once an EMR is adopted, a need exists to continue evaluations such as this because, ultimately, the gold standard should be improved patient care processes and better outcomes for patients.

Although the prevalence of coronary heart disease and death from acute myocardial infarction (AMI) have declined steadily, about 935,000 heart attacks still occur annually in the United States, with approximately one‐third of these being fatal.[1, 2, 3] Studies have demonstrated decreased 30‐day and longer‐term mortality in AMI patients who receive evidence‐based treatment, including aspirin, ‐blockers, angiotensin‐converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs), anticoagulation therapy, and statins.[4, 5, 6, 7] Despite clinical practice guidelines (CPGs) outlining evidence‐based care and considerable efforts to implement processes that improve patient outcomes, delivery of effective therapy remains suboptimal.[8] For example, the Hospital Quality Alliance Program[9] found that in AMI patients, use of aspirin on admission was only 81% to 92%, ‐blocker on admission 75% to 85%, and ACE inhibitors for left ventricular dysfunction 71% to 74%.

Efforts to increase adherence to CPGs and improve patient outcomes in AMI have resulted in variable degrees of success. They include promotion of CPGs,[4, 5, 6, 7] physician education with feedback, report cards, care paths, registries,[10] Joint Commission standardized measures,[11] and paper checklists or order sets (OS).[12, 13]

In this report, we describe the association between use of an evidence‐based, electronic OS for AMI (AMI‐OS) and better adherence to CPGs. This AMI‐OS was implemented in the inpatient electronic medical records (EMRs) of a large integrated healthcare delivery system, Kaiser Permanente Northern California (KPNC). The purpose of our investigation was to determine (1) whether use of the AMI‐OS was associated with improved AMI processes and patient outcomes, and (2) whether these associations persisted after risk adjustment using a comprehensive severity of illness scoring system.

MATERIALS AND METHODS

This project was approved by the KPNC institutional review board.

Under a mutual exclusivity arrangement, salaried physicians of The Permanente Medical Group, Inc., care for 3.4 million Kaiser Foundation Health Plan, Inc. members at facilities owned by Kaiser Foundation Hospitals, Inc. All KPNC facilities employ the same information systems with a common medical record number and can track care covered by the plan but delivered elsewhere.[14] Our setting consisted of 21 KPNC hospitals described in previous reports,[15, 16, 17, 18] using the same commercially available EMR system that includes computerized physician order entry (CPOE). Deployment of the customized inpatient Epic EMR (www.epicsystems.com), known internally as KP HealthConnect (KPHC), began in 2006 and was completed in 2010.

In this EMR's CPOE, physicians have options to select individual orders (a la carte) or they can utilize an OS, which is a collection of the most appropriate orders associated with specific diagnoses, procedures, or treatments. The evidence‐based AMI‐OS studied in this project was developed by a multidisciplinary team (for detailed components see Supporting Appendix 1Appendix 5 in the online version of this article).

Our study focused on the first set of hospital admission orders for patients with AMI. The study sample consisted of patients meeting these criteria: (1) age 18 years at admission; (2) admitted to a KPNC hospital for an overnight stay between September 28, 2008 and December 31, 2010; (3) principal diagnosis was AMI (International Classification of Diseases, 9th Revision [ICD‐9][19] codes 410.00, 01, 10, 11, 20, 21, 30, 31, 40, 41, 50, 51, 60, 61, 70, 71, 80, 90, and 91); and (4) KPHC had been operational at the hospital for at least 3 months to be included (for assembly descriptions see Supporting Appendices 15 in the online version of this article). At the study hospitals, troponin I was measured using the Beckman Access AccuTnI assay (Beckman Coulter, Inc., Brea, CA), whose upper reference limit (99th percentile) is 0.04 ng/mL. We excluded patients initially hospitalized for AMI at a non‐KPNC site and transferred into a study hospital.

The data processing methods we employed have been detailed elsewhere.[14, 15, 17, 20, 21, 22] The dependent outcome variables were total hospital length of stay, inpatient mortality, 30‐day mortality, and all‐cause rehospitalization within 30 days of discharge. Linked state mortality data were unavailable for the entire study period, so we ascertained 30‐day mortality based on the combination of KPNC patient demographic data and publicly available Social Security Administration decedent files. We ascertained rehospitalization by scanning KPNC hospitalization databases, which also track out‐of‐plan use.

The dependent process variables were use of aspirin within 24 hours of admission, ‐blockers, anticoagulation, ACE inhibitors or ARBs, and statins. The primary independent variable of interest was whether or not the admitting physician employed the AMI‐OS when admission orders were entered. Consequently, this variable is dichotomous (AMI‐OS vs a la carte).

We controlled for acute illness severity and chronic illness burden using a recent modification[22] of an externally validated risk‐adjustment system applicable to all hospitalized patients.[15, 16, 23, 24, 25] Our methodology included vital signs, neurological status checks, and laboratory test results obtained in the 72 hours preceding hospital admission; comorbidities were captured longitudinally using data from the year preceding hospitalization (for comparison purposes, we also assigned a Charlson Comorbidity Index score[26]).

End‐of‐life care directives are mandatory on admission at KPNC hospitals. Physicians have 4 options: full code, partial code, do not resuscitate, and comfort care only. Because of small numbers in some categories, we collapsed these 4 categories into full code and not full code. Because patients' care directives may change, we elected to capture the care directive in effect when a patient first entered a hospital unit other than the emergency department (ED).

Two authors (M.B., P.C.L.), one of whom is a board‐certified cardiologist, reviewed all admission electrocardiograms and made a consensus determination as to whether or not criteria for ST‐segment elevation myocardial infarction (STEMI) were present (ie, new ST‐segment elevation or left bundle branch block); we also reviewed the records of all patients with missing troponin I data to confirm the AMI diagnosis.

RESULTS

Table 1 summarizes the characteristics of the 5879 patients. It shows that AMI‐OS patients were more likely to receive evidence‐based therapies for AMI (aspirin, ‐blockers, ACE inhibitors or ARBs, anticoagulation, and statins) and had a 46% lower mortality rate in hospital (3.51 % vs 6.52%) and 33% lower rate at 30 days (5.66% vs 8.48%). AMI‐OS patients were also found to be at lower risk for an adverse outcome than nonAMI‐OS patients. The AMI‐OS patients had lower peak troponin I values, severity of illness (lower Laboratory‐Based Acute Physiology Score, version 2 [LAPS2] scores), comorbidity burdens (lower Comorbidity Point Score, version 2 [COPS2] and Charlson scores), and global predicted mortality risk. AMI‐OS patients were also less likely to have required intensive care. AMI‐OS patients were at higher risk of death than nonAMI‐OS patients with respect to only 1 variable (being full code at the time of admission), but although this difference was statistically significant, it was of minor clinical impact (86% vs 88%).

Table 2 shows the result of a logistic regression model in which the dependent variable was inpatient mortality and either the 5 evidence‐based therapies or the total number of evidence‐based therapies are the dependent variables. ‐blocker, statin, and ACE inhibitor or ARB therapies all had a protective effect on mortality, with odds ratios ranging from 0.48 (95% confidence interval [CI]: 0.36‐0.64), 0.63 (95% CI: 0.45‐0.89), and 0.40 (95% CI: 0.30‐0.53), respectively. An increased number of therapies also had a beneficial effect on inpatient mortality, with patients having 3 or more of the evidence‐based therapies showing an adjusted odds ratio (AOR) of 0.49 (95% CI: 0.33‐0.73), 4 or more therapies an AOR of 0.29 (95% CI: 0.20‐0.42), and 0.17 (95% CI: 0.11‐0.25) for 5 or more therapies.

Table 3 shows that the use of the AMI‐OS is protective, with an AOR of 0.59 and a 95% CI of 0.45‐0.76. Table 3 also shows that the most potent predictors were comorbidity burden (AOR: 1.07, 95% CI: 1.03‐1.10 per 10 COPS2 points), severity of illness (AOR: 1.09, 95% CI: 1.07‐1.12 per 10 LAPS2 points), STEMI (AOR: 3.86, 95% CI: 2.68‐5.58), and timing of cardiac catheterization referral occurring immediately prior to or during the admission (AOR: 0.37, 95% CI: 0.27‐0.51). The statistical significance of the AMI‐OS effect disappears when both AMI‐OS and the individual therapies are included in the same model (see Supporting Information, Appendices 15, in the online version of this article).

Table 4 shows separately the average treatment effect (ATE) and average treatment effect for the treated (ATT) of AMI‐OS and of increasing number of therapies on other outcomes (30‐day mortality, LOS, and readmission). Both the ATE and ATT show that the use of the AMI‐OS was significantly protective with respect to mortality and total hospital LOS but not significant with respect to readmission. The effect of the number of therapies on mortality is significantly higher with increasing number of therapies. For example, patients who received 5 therapies had an average treatment effect on 30‐day inpatient mortality of 0.23 (95% CI: 0.15‐0.35) compared to 0.64 (95% CI: 0.43‐0.96) for 3 therapies, almost a 3‐fold difference. The effects of increasing number of therapies were not significant for LOS or readmission. A sensitivity analysis in which the 535 STEMI patients were removed showed essentially the same results, so it is not reported here.

To further elucidate possible reasons why physicians did not use the AMI‐OS, the lead author reviewed 105 randomly selected records where the AMI‐OS was not used, 5 records from each of the 21 study hospitals. This review found that in 36% of patients, the AMI‐OS was not used because emergent catheterization or transfer to a facility with percutaneous coronary intervention capability occurred. Presence of other significant medical conditions, including critical illness, was the reason in 17% of these cases, patient or family refusal of treatments in 8%, issues around end‐of‐life care in 3%, and specific medical contraindications in 1%. In the remaining 34%, no reason for not using the AMI‐OS could be identified.

DISCUSSION

We evaluated the use of an evidence‐based electronic AMI‐OS embedded in a comprehensive EMR and found that it was beneficial. Its use was associated with increased adherence to evidence‐based therapies, which in turn were associated with improved outcomes. Using data from a large cohort of hospitalized AMI patients in 21 community hospitals, we were able to use risk adjustment that included physiologic illness severity to adjust for baseline mortality risk. Patients in whom the AMI‐OS was employed tended to be at lower risk; nonetheless, after controlling for confounding variables and adjusting for bias using propensity scores, the AMI‐OS was associated with increased use of evidence‐based therapies and decreased mortality. Most importantly, it appears that the benefits of the OS were not just due to increased receipt of individual recommended therapies, but to increased concurrent receipt of multiple recommended therapies.

Modern EMRs have great potential for significant improvements in the quality, efficiency, and safety of care provided,[36] and our study highlights this potential. However, a number of important limitations to our study must be considered. Although we had access to a very rich dataset, we could not control for all possible confounders, and our risk adjustment cannot match the level of information available to clinicians. In particular, the measurements available to us with respect to cardiac risk are limited. Thus, we have to recognize that the strength of our findings does not approximate that of a randomized trial, and one would expect that the magnitude of the beneficial association would fall under more controlled conditions. Resource limitations also did not permit us to gather more time course data (eg, sequential measurements of patient instability, cardiac damage, or use of recommended therapies), which could provide a better delineation of differences in both processes and outcomes.

Limitations also exist to the generalizability of the use of order sets in other settings that go beyond the availability of a comprehensive EMR. Our study population was cared for in a setting with an unusually high level of integration.[1] For example, KPNC has an elaborate administrative infrastructure for training in the use of the EMR as well as ensuring that order sets are not just evidence‐based, but that they are perceived by clinicians to be of significant value. This infrastructure, established to ensure physician buy‐in, may not be easy to replicate in smaller or less‐integrated settings. Thus, it is conceivable that factors other than the degree of support during the EMR deployments can affect rates of order set use.

Although our use of counterfactual methods included illness severity (LAPS2) and longitudinal comorbidity burden (COPS2), which are not yet available outside highly integrated delivery services employing comprehensive EMRs, it is possible they are insufficient. We cannot exclude the possibility that other biases or patient characteristics were present that led clinicians to preferentially employ the electronic order set in some patients but not in others. One could also argue that future studies should consider using overall adherence to recommended AMI treatment guidelines as a risk adjustment tool that would permit one to analyze what other factors may be playing a role in residual differences in patient outcomes. Last, one could object to our inclusion of STEMI patients; however, this was not a study on optimum treatment strategies for STEMI patients. Rather, it was a study on the impact on AMI outcomes of a specific component of computerized order entry outside the research setting.

Despite these limitations, we believe that our findings provide strong support for the continued use of electronic evidence‐based order sets in the inpatient medical setting. Once the initial implementation of a comprehensive EMR has occurred, deployment of these electronic order sets is a relatively inexpensive but effective method to foster compliance with evidence‐based care.

Future research in healthcare information technology can take a number of directions. One important area, of course, revolves around ways to promote enhanced physician adoption of EMRs. Our audit of records where the AMI‐OS was not used found that specific reasons for not using the order set (eg, treatment refusals, emergent intervention) were present in two‐thirds of the cases. This suggests that future analyses of adherence involving EMRs and CPOE implementation should take a more nuanced look at how order entry is actually enabled. It may be that understanding how order sets affect care enhances clinician acceptance and thus could serve as an incentive to EMR adoption. However, once an EMR is adopted, a need exists to continue evaluations such as this because, ultimately, the gold standard should be improved patient care processes and better outcomes for patients.

Patients in general medicalsurgical wards who experience unplanned transfer to the intensive care unit (ICU) have increased mortality and morbidity.13 Using an externally validated methodology permitting assessment of illness severity and mortality risk among all hospitalized patients,4, 5 we recently documented observed‐to‐expected mortality ratios >3.0 and excess length of stay of 10 days among patients who experienced such transfers.6

It is possible to predict adverse outcomes among monitored patients (eg, patients in the ICU or undergoing continuous electronic monitoring).7, 8 However, prediction of unplanned transfers among medicalsurgical ward patients presents challenges. Data collection (vital signs and laboratory tests) is relatively infrequent. The event rate (3% of hospital admissions) is low, and the rate in narrow time periods (eg, 12 hours) is extremely low: a hospital with 4000 admissions per year might experience 1 unplanned transfer to the ICU every 3 days. Not surprisingly, performance of models suitable for predicting ward patients' need for intensive care within narrow time frames have been disappointing.9 The Modified Early Warning Score (MEWS), has a c‐statistic, or area under the receiver operator characteristic of 0.67,1012 and our own model incorporating 14 laboratory tests, but no vital signs, has excellent performance with respect to predicting inpatient mortality, but poor performance with respect to unplanned transfer.6

In this report, we describe the development and validation of a complex predictive model suitable for use with ward patients. Our objective for this work was to develop a predictive model based on clinical and physiologic data available in real time from a comprehensive electronic medical record (EMR), not a clinically intuitive, manually assigned tool. The outcome of interest was unplanned transfer from the ward to the ICU, or death on the ward in a patient who was full code. This model has been developed as part of a regional effort to decrease preventable mortality in the Northern California Kaiser Permanente Medical Care Program (KPMCP), an integrated healthcare delivery system with 22 hospitals.

MATERIALS AND METHODS

For additional details, see the Supporting Information, Appendices 112, in the online version of this article.

This project was approved by the KPMCP Institutional Board for the Protection of Human Subjects.

The Northern California KPMCP serves a total population of approximately 3.3 million members. All Northern California KPMCP hospitals and clinics employ the same information systems with a common medical record number and can track care covered by the plan but delivered elsewhere. Databases maintained by the KPMCP capture admission and discharge times, admission and discharge diagnoses and procedures (assigned by professional coders), bed histories permitting quantification of intra‐hospital transfers, inter‐hospital transfers, as well as the results of all inpatient and outpatient laboratory tests. In July 2006, the KPMCP began deployment of the EMR developed by Epic Systems Corporation (www.epic. com), which has been adapted for the KPMCP and is known as KP HealthConnect (KPHC) in its hospitals. The last of these 22 hospitals went online in March 2010.

Our setting consisted of 14 hospitals in which the KPHC inpatient EMR had been running for at least 3 months (the KPMCP Antioch, Fremont, Hayward, Manteca, Modesto, Roseville, Sacramento, Santa Clara, San Francisco, Santa Rosa, South Sacramento, South San Francisco, Santa Teresa, and Walnut Creek hospitals). We have described the general characteristics of KPMCP hospitals elsewhere.4, 6 Our initial study population consisted of all patients admitted to these hospitals who met the following criteria: hospitalization began from November 1, 2006 through December 31, 2009; initial hospitalization occurred at a Northern California KPMCP hospital (ie, for inter‐hospital transfers, the first hospital stay occurred within the KPMCP); age 18 years; hospitalization was not for childbirth; and KPHC had been operational at the hospital for at least 3 months.

RESULTS

During the study period, a total of 102,488 patients experienced 145,335 hospitalizations at the study hospitals. We removed 66 patients with 138 hospitalizations for data quality reasons, leaving us with our initial study sample of 102,422 patients whose characteristics are summarized in Table 1. Table 1, in which the unit of analysis is an individual patient, shows that patients who experienced the primary outcome were similar to those patients described in our previous report, in terms of their characteristics on admission as well as in experiencing excess morbidity and mortality.6

Figure 1shows how we developed the analysis cohort, by removing patients with a comfort‐care‐only order placed within 4 hours after admission (369 patients/744 hospitalizations) and patients who were never admitted to the ward or TCU (7,220/10,574). This left a cohort consisting of 94,833 patients who experienced 133,879 hospitalizations spanning a total of 1,079,062 shifts. We then removed shifts where: 1) a patient was not on the ward at the start of a shift, or was on the ward for <4 hours of a shift; 2) the patient had a comfort‐care order in place at the start of the shift; and 3) the patient died and was ineligible to be a case (the patient had a DNR order in place or died in the ICU). The final cohort eligible for sampling consisted of 846,907 shifts, which involved a total of 92,797 patients and 130,627 hospitalizations. There were a total of 4,036 event shifts, which included 3,224 where a patient was transferred from the ward to the ICU, 717 from the TCU to the ICU, and 95 where a patient died on the ward or TCU without a DNR order in place. We then randomly selected 39,782 comparison shifts. Thus, our final cohort for analysis included 4,036 event shifts (1,979 derivation/2,057 validation and 39,782 comparison shifts (19,509/20,273). As a secondary validation, we also applied model coefficients to the 429 event shifts excluded due to the <4‐hour length‐of‐stay requirement.

Figure 1

Table 2 compares event shifts with comparison shifts. In the 24 hours preceding ICU transfer, patients who were subsequently transferred had statistically significant, but not necessarily clinically significant, differences in terms of these variables. However, missing laboratory data were more common, ranging from 18% to 31% of all shifts (we did not incorporate laboratory tests where 35% of the shifts had missing data for that test).

After conducting multiple analyses using the derivation dataset, we developed 24 submodels, a compromise between our finding that primary‐condition‐specific models showed better performance and the fact that we had very few events among patients with certain primary conditions (eg, pericarditis/valvular heart disease), which forced us to create composite categories (eg, a category pooling patients with pericarditis, atherosclerosis, and peripheral vascular disease). Table 3 lists variables included in our final submodels.

Table 4 summarizes key results in the validation dataset. Across all diagnoses, the MEWS(re) had c‐statistic of 0.709 (95% confidence interval, 0.6970.721) in the derivation dataset and 0.698 (0.6860.710) in the validation dataset. In the validation dataset, the MEWS(re) performed best among patients with a set of gastrointestinal diagnoses (c = 0.792; 0.7260.857) and worst among patients with congestive heart failure (0.541; 0.5000.620). In contrast, across all primary conditions, the EMR‐based models had a c‐statistic of 0.845 (0.8260.863) in the derivation dataset and 0.775 (0.7530.797) in the validation dataset. In the validation dataset, the EMR‐based models also performed best among patients with a set of gastrointestinal diagnoses (0.841; 0.7830.897) and worst among patients with congestive heart failure (0.683; 0.6100.755). A negative correlation (R = 0.63) was evident between the number of event shifts in a submodel and the drop in the c‐statistic seen in the validation dataset.

We also compared model performance when our datasets were restricted to 1 randomly selected observation per patient; in these analyses, the total number of event shifts was 3,647 and the number of comparison shifts was 29,052. The c‐statistic for the MEWS(re) in the derivation dataset was 0.709 (0.6940.725); in the validation dataset, it was 0.698 (0.6920.714). The corresponding values for the EMR‐based models were 0.856 (0.8350.877) and 0.780 (0.7560.804). We also tested models in which, instead of dropping shifts with missing vital signs, we imputed missing vital signs to their normal value. The c‐statistic for the EMR‐based model with imputed vital sign values was 0.842 (0.8230.861) in the derivation dataset and 0.773 (0.7520.794) in the validation dataset. Lastly, we applied model coefficients to a dataset consisting of 4,290 randomly selected comparison shifts plus the 429 shifts excluded because of the 4‐hour length‐of‐stay criterion. The c‐statistic for this analysis was 0.756 (0.7030.809).

As a general rule, the EMR‐based models were more than twice as efficient as the MEWS(re). For example, a MEWS(re) threshold of 6 as the trigger for an alarm would identify 15% of all transfers to the ICU, with 34.4 false alarms for each transfer; in contrast, using the EMR‐based approach to identify 15% of all transfers, there were 14.5 false alarms for each transfer. Applied to the entire KPMCP Northern California Region, using the MEWS(re), a total of 52 patients per day would need to be evaluated, but only 22 per day using the EMR‐based approach. If one employed a MEWS(re) threshold of 4, this would lead to identification of 44% of all transfers, with a ratio of 69 false alarms for each transfer; using the EMR, the ratio would be 34 to 1. Across the entire KPMCP, a total of 276 patients per day (or about 19.5 a day per hospital) would need to be evaluated using the MEWS(re), but only 136 (or about 9.5 per hospital per day) using the EMR.

DISCUSSION

Using data from a large hospital cohort, we have developed a predictive model suitable for use in non‐ICU populations cared for in integrated healthcare settings with fully automated EMRs. The overall performance of our model, which incorporates acute physiology, diagnosis, and longitudinal data, is superior to the predictive ability of a model that can be assigned manually. This is not surprising, given that scoring systems such as the MEWS make an explicit tradeoff losing information found in multiple variables in exchange for ease of manual assignment. Currently, the model described in this report is being implemented in a simulated environment, a final safety test prior to piloting real‐time provision of probability estimates to clinicians and nurses. Though not yet ready for real‐time use, it is reasonable for our model to be tested using the KPHC shadow server, since evaluation in a simulated environment constitutes a critical evaluation step prior to deployment for clinical use. We also anticipate further refinement and revalidation to occur as more inpatient data become available in the KPMCP and elsewhere.

A number of limitations to our approach must be emphasized. In developing our models, we determined that, while modeling by clinical condition was important, the study outcome was rare for some primary conditions. In these diagnostic groups, which accounted for 12.5% of the event shifts and 10.6% of the comparison shifts, the c‐statistic in the validation dataset was <0.70. Since all 22 KPMCP hospitals are now online and will generate an additional 150,000 adult hospitalizations per year, we expect to be able to correct this problem prior to deployment of these models for clinical use. Having additional data will permit us to improve model discrimination and thus decrease the evaluation‐to‐detection ratio. In future iterations of these models, more experimentation with grouping of International Classification of Diseases (ICD) codes may be required. The problem of grouping ICD codes is not an easy one to resolve, in that diagnoses in the grouping must share common pathophysiology while having a grouping with a sufficient number of adverse events for stable statistical models.

Ideally, it would have been desirable to employ a more objective measure of deterioration, since the decision to transfer a patient to the ICU is discretionary. However, we have found that key data points needed to define such a measure (eg, vital signs) are not consistently charted when a patient deterioratesthis is not surprising outside the research setting, given that nurses and physicians involved in a transfer may be focusing on caring for the patient rather than immediately charting. Given the complexities of end‐of‐life‐care decision‐making, we could not employ death as the outcome of interest. A related issue is that our model does not differentiate between reasons for needing transfer to the ICU, an issue recently discussed by Bapoje et al.18

Our model does not address an important issue raised by Bapoje et al18 and Litvak, Pronovost, and others,19, 20 namely, whether a patient should have been admitted to a non‐ICU setting in the first place. Our team is currently developing a model for doing exactly this (providing decision support for triage in the emergency department), but discussion of this methodology is outside the scope of this article.

Because of resource and data limitations, our model also does not include newborns, children, women admitted for childbirth, or patients transferred from non‐KPMCP hospitals. However, the approach described here could serve as a starting point for developing models for these other populations.

The generalizability of our model must also be considered. The Northern California KPMCP is unusual in having large electronic databases that include physiologic as well as longitudinal patient data. Many hospitals cannot take advantage of all the methods described here. However, the methods we employed could be modified for use by hospital systems in countries such as Great Britain and Canada, and entities such as the Veterans Administration Hospital System in the United States. The KPMCP population, an insured population with few barriers to access, is healthier than the general population, and some population subsets are underrepresented in our cohort. Practice patterns may also vary. Nonetheless, the model described here could serve as a good starting point for future collaborative studies, and it would be possible to develop models suitable for use by stand‐alone hospitals (eg, recalibrating so that one used a Charlson comorbidity21 score based on present on‐admission codes rather than the COPS).

The need for early detection of patient deterioration has played a major role in the development of rapid response teams, as well as scores such as the MEWS. In particular, entities such as the Institute for Healthcare Improvement have advocated the use of early warning systems.22 However, having a statistically robust model to support an early warning system is only part of the solution, and a number of new challenges must then be addressed. The first is actual electronic deployment. Existing inpatient EMRs were not designed with complex calculations in mind, and we anticipate that some degradation in performance will occur when we test our models using real‐time data capture. As Bapoje et al point out, simply having an alert may be insufficient, since not all transfers are preventable.18 Early warning systems also raise ethical issues (for example, what should be done if an alert leads a clinician to confront the fact that an end‐of‐life‐care discussion needs to occur?). From a research perspective, if one were to formally test the benefits of such models, it would be critical to define outcome measures other than death (which is strongly affected by end‐of‐life‐care decisions) or ICU transfer (which is often desirable).

In conclusion, we have developed an approach for predicting impending physiologic deterioration of hospitalized adults outside the ICU. Our approach illustrates how organizations can take maximal advantage of EMRs in a manner that exceeds meaningful use specifications.23, 24 Our study highlights the possibility of using fully automated EMR data for building and applying sophisticated statistical models in settings other than the highly monitored ICU without the need for additional equipment. It also expands the universe of severity scoring to one in which probability estimates are provided in real time and throughout an entire hospitalization. Model performance will undoubtedly improve over time, as more patient data become available. Although our approach has important limitations, it is suitable for testing using real‐time data in a simulated environment. Such testing would permit identification of unanticipated problems and quantification of the degradation of model performance due to real life factors, such as delays in vital signs charting or EMR system brownouts. It could also serve as the springboard for future collaborative studies, with a broader population base, in which the EMR becomes a tool for care, not just documentation.

Patients in general medicalsurgical wards who experience unplanned transfer to the intensive care unit (ICU) have increased mortality and morbidity.13 Using an externally validated methodology permitting assessment of illness severity and mortality risk among all hospitalized patients,4, 5 we recently documented observed‐to‐expected mortality ratios >3.0 and excess length of stay of 10 days among patients who experienced such transfers.6

It is possible to predict adverse outcomes among monitored patients (eg, patients in the ICU or undergoing continuous electronic monitoring).7, 8 However, prediction of unplanned transfers among medicalsurgical ward patients presents challenges. Data collection (vital signs and laboratory tests) is relatively infrequent. The event rate (3% of hospital admissions) is low, and the rate in narrow time periods (eg, 12 hours) is extremely low: a hospital with 4000 admissions per year might experience 1 unplanned transfer to the ICU every 3 days. Not surprisingly, performance of models suitable for predicting ward patients' need for intensive care within narrow time frames have been disappointing.9 The Modified Early Warning Score (MEWS), has a c‐statistic, or area under the receiver operator characteristic of 0.67,1012 and our own model incorporating 14 laboratory tests, but no vital signs, has excellent performance with respect to predicting inpatient mortality, but poor performance with respect to unplanned transfer.6

In this report, we describe the development and validation of a complex predictive model suitable for use with ward patients. Our objective for this work was to develop a predictive model based on clinical and physiologic data available in real time from a comprehensive electronic medical record (EMR), not a clinically intuitive, manually assigned tool. The outcome of interest was unplanned transfer from the ward to the ICU, or death on the ward in a patient who was full code. This model has been developed as part of a regional effort to decrease preventable mortality in the Northern California Kaiser Permanente Medical Care Program (KPMCP), an integrated healthcare delivery system with 22 hospitals.

MATERIALS AND METHODS

For additional details, see the Supporting Information, Appendices 112, in the online version of this article.

This project was approved by the KPMCP Institutional Board for the Protection of Human Subjects.

The Northern California KPMCP serves a total population of approximately 3.3 million members. All Northern California KPMCP hospitals and clinics employ the same information systems with a common medical record number and can track care covered by the plan but delivered elsewhere. Databases maintained by the KPMCP capture admission and discharge times, admission and discharge diagnoses and procedures (assigned by professional coders), bed histories permitting quantification of intra‐hospital transfers, inter‐hospital transfers, as well as the results of all inpatient and outpatient laboratory tests. In July 2006, the KPMCP began deployment of the EMR developed by Epic Systems Corporation (www.epic. com), which has been adapted for the KPMCP and is known as KP HealthConnect (KPHC) in its hospitals. The last of these 22 hospitals went online in March 2010.

Our setting consisted of 14 hospitals in which the KPHC inpatient EMR had been running for at least 3 months (the KPMCP Antioch, Fremont, Hayward, Manteca, Modesto, Roseville, Sacramento, Santa Clara, San Francisco, Santa Rosa, South Sacramento, South San Francisco, Santa Teresa, and Walnut Creek hospitals). We have described the general characteristics of KPMCP hospitals elsewhere.4, 6 Our initial study population consisted of all patients admitted to these hospitals who met the following criteria: hospitalization began from November 1, 2006 through December 31, 2009; initial hospitalization occurred at a Northern California KPMCP hospital (ie, for inter‐hospital transfers, the first hospital stay occurred within the KPMCP); age 18 years; hospitalization was not for childbirth; and KPHC had been operational at the hospital for at least 3 months.

RESULTS

During the study period, a total of 102,488 patients experienced 145,335 hospitalizations at the study hospitals. We removed 66 patients with 138 hospitalizations for data quality reasons, leaving us with our initial study sample of 102,422 patients whose characteristics are summarized in Table 1. Table 1, in which the unit of analysis is an individual patient, shows that patients who experienced the primary outcome were similar to those patients described in our previous report, in terms of their characteristics on admission as well as in experiencing excess morbidity and mortality.6

Figure 1shows how we developed the analysis cohort, by removing patients with a comfort‐care‐only order placed within 4 hours after admission (369 patients/744 hospitalizations) and patients who were never admitted to the ward or TCU (7,220/10,574). This left a cohort consisting of 94,833 patients who experienced 133,879 hospitalizations spanning a total of 1,079,062 shifts. We then removed shifts where: 1) a patient was not on the ward at the start of a shift, or was on the ward for <4 hours of a shift; 2) the patient had a comfort‐care order in place at the start of the shift; and 3) the patient died and was ineligible to be a case (the patient had a DNR order in place or died in the ICU). The final cohort eligible for sampling consisted of 846,907 shifts, which involved a total of 92,797 patients and 130,627 hospitalizations. There were a total of 4,036 event shifts, which included 3,224 where a patient was transferred from the ward to the ICU, 717 from the TCU to the ICU, and 95 where a patient died on the ward or TCU without a DNR order in place. We then randomly selected 39,782 comparison shifts. Thus, our final cohort for analysis included 4,036 event shifts (1,979 derivation/2,057 validation and 39,782 comparison shifts (19,509/20,273). As a secondary validation, we also applied model coefficients to the 429 event shifts excluded due to the <4‐hour length‐of‐stay requirement.

Figure 1

Table 2 compares event shifts with comparison shifts. In the 24 hours preceding ICU transfer, patients who were subsequently transferred had statistically significant, but not necessarily clinically significant, differences in terms of these variables. However, missing laboratory data were more common, ranging from 18% to 31% of all shifts (we did not incorporate laboratory tests where 35% of the shifts had missing data for that test).

After conducting multiple analyses using the derivation dataset, we developed 24 submodels, a compromise between our finding that primary‐condition‐specific models showed better performance and the fact that we had very few events among patients with certain primary conditions (eg, pericarditis/valvular heart disease), which forced us to create composite categories (eg, a category pooling patients with pericarditis, atherosclerosis, and peripheral vascular disease). Table 3 lists variables included in our final submodels.

Table 4 summarizes key results in the validation dataset. Across all diagnoses, the MEWS(re) had c‐statistic of 0.709 (95% confidence interval, 0.6970.721) in the derivation dataset and 0.698 (0.6860.710) in the validation dataset. In the validation dataset, the MEWS(re) performed best among patients with a set of gastrointestinal diagnoses (c = 0.792; 0.7260.857) and worst among patients with congestive heart failure (0.541; 0.5000.620). In contrast, across all primary conditions, the EMR‐based models had a c‐statistic of 0.845 (0.8260.863) in the derivation dataset and 0.775 (0.7530.797) in the validation dataset. In the validation dataset, the EMR‐based models also performed best among patients with a set of gastrointestinal diagnoses (0.841; 0.7830.897) and worst among patients with congestive heart failure (0.683; 0.6100.755). A negative correlation (R = 0.63) was evident between the number of event shifts in a submodel and the drop in the c‐statistic seen in the validation dataset.

We also compared model performance when our datasets were restricted to 1 randomly selected observation per patient; in these analyses, the total number of event shifts was 3,647 and the number of comparison shifts was 29,052. The c‐statistic for the MEWS(re) in the derivation dataset was 0.709 (0.6940.725); in the validation dataset, it was 0.698 (0.6920.714). The corresponding values for the EMR‐based models were 0.856 (0.8350.877) and 0.780 (0.7560.804). We also tested models in which, instead of dropping shifts with missing vital signs, we imputed missing vital signs to their normal value. The c‐statistic for the EMR‐based model with imputed vital sign values was 0.842 (0.8230.861) in the derivation dataset and 0.773 (0.7520.794) in the validation dataset. Lastly, we applied model coefficients to a dataset consisting of 4,290 randomly selected comparison shifts plus the 429 shifts excluded because of the 4‐hour length‐of‐stay criterion. The c‐statistic for this analysis was 0.756 (0.7030.809).

As a general rule, the EMR‐based models were more than twice as efficient as the MEWS(re). For example, a MEWS(re) threshold of 6 as the trigger for an alarm would identify 15% of all transfers to the ICU, with 34.4 false alarms for each transfer; in contrast, using the EMR‐based approach to identify 15% of all transfers, there were 14.5 false alarms for each transfer. Applied to the entire KPMCP Northern California Region, using the MEWS(re), a total of 52 patients per day would need to be evaluated, but only 22 per day using the EMR‐based approach. If one employed a MEWS(re) threshold of 4, this would lead to identification of 44% of all transfers, with a ratio of 69 false alarms for each transfer; using the EMR, the ratio would be 34 to 1. Across the entire KPMCP, a total of 276 patients per day (or about 19.5 a day per hospital) would need to be evaluated using the MEWS(re), but only 136 (or about 9.5 per hospital per day) using the EMR.

DISCUSSION

Using data from a large hospital cohort, we have developed a predictive model suitable for use in non‐ICU populations cared for in integrated healthcare settings with fully automated EMRs. The overall performance of our model, which incorporates acute physiology, diagnosis, and longitudinal data, is superior to the predictive ability of a model that can be assigned manually. This is not surprising, given that scoring systems such as the MEWS make an explicit tradeoff losing information found in multiple variables in exchange for ease of manual assignment. Currently, the model described in this report is being implemented in a simulated environment, a final safety test prior to piloting real‐time provision of probability estimates to clinicians and nurses. Though not yet ready for real‐time use, it is reasonable for our model to be tested using the KPHC shadow server, since evaluation in a simulated environment constitutes a critical evaluation step prior to deployment for clinical use. We also anticipate further refinement and revalidation to occur as more inpatient data become available in the KPMCP and elsewhere.

A number of limitations to our approach must be emphasized. In developing our models, we determined that, while modeling by clinical condition was important, the study outcome was rare for some primary conditions. In these diagnostic groups, which accounted for 12.5% of the event shifts and 10.6% of the comparison shifts, the c‐statistic in the validation dataset was <0.70. Since all 22 KPMCP hospitals are now online and will generate an additional 150,000 adult hospitalizations per year, we expect to be able to correct this problem prior to deployment of these models for clinical use. Having additional data will permit us to improve model discrimination and thus decrease the evaluation‐to‐detection ratio. In future iterations of these models, more experimentation with grouping of International Classification of Diseases (ICD) codes may be required. The problem of grouping ICD codes is not an easy one to resolve, in that diagnoses in the grouping must share common pathophysiology while having a grouping with a sufficient number of adverse events for stable statistical models.

Ideally, it would have been desirable to employ a more objective measure of deterioration, since the decision to transfer a patient to the ICU is discretionary. However, we have found that key data points needed to define such a measure (eg, vital signs) are not consistently charted when a patient deterioratesthis is not surprising outside the research setting, given that nurses and physicians involved in a transfer may be focusing on caring for the patient rather than immediately charting. Given the complexities of end‐of‐life‐care decision‐making, we could not employ death as the outcome of interest. A related issue is that our model does not differentiate between reasons for needing transfer to the ICU, an issue recently discussed by Bapoje et al.18

Our model does not address an important issue raised by Bapoje et al18 and Litvak, Pronovost, and others,19, 20 namely, whether a patient should have been admitted to a non‐ICU setting in the first place. Our team is currently developing a model for doing exactly this (providing decision support for triage in the emergency department), but discussion of this methodology is outside the scope of this article.

Because of resource and data limitations, our model also does not include newborns, children, women admitted for childbirth, or patients transferred from non‐KPMCP hospitals. However, the approach described here could serve as a starting point for developing models for these other populations.

The generalizability of our model must also be considered. The Northern California KPMCP is unusual in having large electronic databases that include physiologic as well as longitudinal patient data. Many hospitals cannot take advantage of all the methods described here. However, the methods we employed could be modified for use by hospital systems in countries such as Great Britain and Canada, and entities such as the Veterans Administration Hospital System in the United States. The KPMCP population, an insured population with few barriers to access, is healthier than the general population, and some population subsets are underrepresented in our cohort. Practice patterns may also vary. Nonetheless, the model described here could serve as a good starting point for future collaborative studies, and it would be possible to develop models suitable for use by stand‐alone hospitals (eg, recalibrating so that one used a Charlson comorbidity21 score based on present on‐admission codes rather than the COPS).

The need for early detection of patient deterioration has played a major role in the development of rapid response teams, as well as scores such as the MEWS. In particular, entities such as the Institute for Healthcare Improvement have advocated the use of early warning systems.22 However, having a statistically robust model to support an early warning system is only part of the solution, and a number of new challenges must then be addressed. The first is actual electronic deployment. Existing inpatient EMRs were not designed with complex calculations in mind, and we anticipate that some degradation in performance will occur when we test our models using real‐time data capture. As Bapoje et al point out, simply having an alert may be insufficient, since not all transfers are preventable.18 Early warning systems also raise ethical issues (for example, what should be done if an alert leads a clinician to confront the fact that an end‐of‐life‐care discussion needs to occur?). From a research perspective, if one were to formally test the benefits of such models, it would be critical to define outcome measures other than death (which is strongly affected by end‐of‐life‐care decisions) or ICU transfer (which is often desirable).

In conclusion, we have developed an approach for predicting impending physiologic deterioration of hospitalized adults outside the ICU. Our approach illustrates how organizations can take maximal advantage of EMRs in a manner that exceeds meaningful use specifications.23, 24 Our study highlights the possibility of using fully automated EMR data for building and applying sophisticated statistical models in settings other than the highly monitored ICU without the need for additional equipment. It also expands the universe of severity scoring to one in which probability estimates are provided in real time and throughout an entire hospitalization. Model performance will undoubtedly improve over time, as more patient data become available. Although our approach has important limitations, it is suitable for testing using real‐time data in a simulated environment. Such testing would permit identification of unanticipated problems and quantification of the degradation of model performance due to real life factors, such as delays in vital signs charting or EMR system brownouts. It could also serve as the springboard for future collaborative studies, with a broader population base, in which the EMR becomes a tool for care, not just documentation.

Patients in general medicalsurgical wards who experience unplanned transfer to the intensive care unit (ICU) have increased mortality and morbidity.13 Using an externally validated methodology permitting assessment of illness severity and mortality risk among all hospitalized patients,4, 5 we recently documented observed‐to‐expected mortality ratios >3.0 and excess length of stay of 10 days among patients who experienced such transfers.6

It is possible to predict adverse outcomes among monitored patients (eg, patients in the ICU or undergoing continuous electronic monitoring).7, 8 However, prediction of unplanned transfers among medicalsurgical ward patients presents challenges. Data collection (vital signs and laboratory tests) is relatively infrequent. The event rate (3% of hospital admissions) is low, and the rate in narrow time periods (eg, 12 hours) is extremely low: a hospital with 4000 admissions per year might experience 1 unplanned transfer to the ICU every 3 days. Not surprisingly, performance of models suitable for predicting ward patients' need for intensive care within narrow time frames have been disappointing.9 The Modified Early Warning Score (MEWS), has a c‐statistic, or area under the receiver operator characteristic of 0.67,1012 and our own model incorporating 14 laboratory tests, but no vital signs, has excellent performance with respect to predicting inpatient mortality, but poor performance with respect to unplanned transfer.6

In this report, we describe the development and validation of a complex predictive model suitable for use with ward patients. Our objective for this work was to develop a predictive model based on clinical and physiologic data available in real time from a comprehensive electronic medical record (EMR), not a clinically intuitive, manually assigned tool. The outcome of interest was unplanned transfer from the ward to the ICU, or death on the ward in a patient who was full code. This model has been developed as part of a regional effort to decrease preventable mortality in the Northern California Kaiser Permanente Medical Care Program (KPMCP), an integrated healthcare delivery system with 22 hospitals.

MATERIALS AND METHODS

For additional details, see the Supporting Information, Appendices 112, in the online version of this article.

This project was approved by the KPMCP Institutional Board for the Protection of Human Subjects.

The Northern California KPMCP serves a total population of approximately 3.3 million members. All Northern California KPMCP hospitals and clinics employ the same information systems with a common medical record number and can track care covered by the plan but delivered elsewhere. Databases maintained by the KPMCP capture admission and discharge times, admission and discharge diagnoses and procedures (assigned by professional coders), bed histories permitting quantification of intra‐hospital transfers, inter‐hospital transfers, as well as the results of all inpatient and outpatient laboratory tests. In July 2006, the KPMCP began deployment of the EMR developed by Epic Systems Corporation (www.epic. com), which has been adapted for the KPMCP and is known as KP HealthConnect (KPHC) in its hospitals. The last of these 22 hospitals went online in March 2010.

Our setting consisted of 14 hospitals in which the KPHC inpatient EMR had been running for at least 3 months (the KPMCP Antioch, Fremont, Hayward, Manteca, Modesto, Roseville, Sacramento, Santa Clara, San Francisco, Santa Rosa, South Sacramento, South San Francisco, Santa Teresa, and Walnut Creek hospitals). We have described the general characteristics of KPMCP hospitals elsewhere.4, 6 Our initial study population consisted of all patients admitted to these hospitals who met the following criteria: hospitalization began from November 1, 2006 through December 31, 2009; initial hospitalization occurred at a Northern California KPMCP hospital (ie, for inter‐hospital transfers, the first hospital stay occurred within the KPMCP); age 18 years; hospitalization was not for childbirth; and KPHC had been operational at the hospital for at least 3 months.

RESULTS

During the study period, a total of 102,488 patients experienced 145,335 hospitalizations at the study hospitals. We removed 66 patients with 138 hospitalizations for data quality reasons, leaving us with our initial study sample of 102,422 patients whose characteristics are summarized in Table 1. Table 1, in which the unit of analysis is an individual patient, shows that patients who experienced the primary outcome were similar to those patients described in our previous report, in terms of their characteristics on admission as well as in experiencing excess morbidity and mortality.6

Figure 1shows how we developed the analysis cohort, by removing patients with a comfort‐care‐only order placed within 4 hours after admission (369 patients/744 hospitalizations) and patients who were never admitted to the ward or TCU (7,220/10,574). This left a cohort consisting of 94,833 patients who experienced 133,879 hospitalizations spanning a total of 1,079,062 shifts. We then removed shifts where: 1) a patient was not on the ward at the start of a shift, or was on the ward for <4 hours of a shift; 2) the patient had a comfort‐care order in place at the start of the shift; and 3) the patient died and was ineligible to be a case (the patient had a DNR order in place or died in the ICU). The final cohort eligible for sampling consisted of 846,907 shifts, which involved a total of 92,797 patients and 130,627 hospitalizations. There were a total of 4,036 event shifts, which included 3,224 where a patient was transferred from the ward to the ICU, 717 from the TCU to the ICU, and 95 where a patient died on the ward or TCU without a DNR order in place. We then randomly selected 39,782 comparison shifts. Thus, our final cohort for analysis included 4,036 event shifts (1,979 derivation/2,057 validation and 39,782 comparison shifts (19,509/20,273). As a secondary validation, we also applied model coefficients to the 429 event shifts excluded due to the <4‐hour length‐of‐stay requirement.

Figure 1

Table 2 compares event shifts with comparison shifts. In the 24 hours preceding ICU transfer, patients who were subsequently transferred had statistically significant, but not necessarily clinically significant, differences in terms of these variables. However, missing laboratory data were more common, ranging from 18% to 31% of all shifts (we did not incorporate laboratory tests where 35% of the shifts had missing data for that test).

After conducting multiple analyses using the derivation dataset, we developed 24 submodels, a compromise between our finding that primary‐condition‐specific models showed better performance and the fact that we had very few events among patients with certain primary conditions (eg, pericarditis/valvular heart disease), which forced us to create composite categories (eg, a category pooling patients with pericarditis, atherosclerosis, and peripheral vascular disease). Table 3 lists variables included in our final submodels.

Table 4 summarizes key results in the validation dataset. Across all diagnoses, the MEWS(re) had c‐statistic of 0.709 (95% confidence interval, 0.6970.721) in the derivation dataset and 0.698 (0.6860.710) in the validation dataset. In the validation dataset, the MEWS(re) performed best among patients with a set of gastrointestinal diagnoses (c = 0.792; 0.7260.857) and worst among patients with congestive heart failure (0.541; 0.5000.620). In contrast, across all primary conditions, the EMR‐based models had a c‐statistic of 0.845 (0.8260.863) in the derivation dataset and 0.775 (0.7530.797) in the validation dataset. In the validation dataset, the EMR‐based models also performed best among patients with a set of gastrointestinal diagnoses (0.841; 0.7830.897) and worst among patients with congestive heart failure (0.683; 0.6100.755). A negative correlation (R = 0.63) was evident between the number of event shifts in a submodel and the drop in the c‐statistic seen in the validation dataset.

We also compared model performance when our datasets were restricted to 1 randomly selected observation per patient; in these analyses, the total number of event shifts was 3,647 and the number of comparison shifts was 29,052. The c‐statistic for the MEWS(re) in the derivation dataset was 0.709 (0.6940.725); in the validation dataset, it was 0.698 (0.6920.714). The corresponding values for the EMR‐based models were 0.856 (0.8350.877) and 0.780 (0.7560.804). We also tested models in which, instead of dropping shifts with missing vital signs, we imputed missing vital signs to their normal value. The c‐statistic for the EMR‐based model with imputed vital sign values was 0.842 (0.8230.861) in the derivation dataset and 0.773 (0.7520.794) in the validation dataset. Lastly, we applied model coefficients to a dataset consisting of 4,290 randomly selected comparison shifts plus the 429 shifts excluded because of the 4‐hour length‐of‐stay criterion. The c‐statistic for this analysis was 0.756 (0.7030.809).

As a general rule, the EMR‐based models were more than twice as efficient as the MEWS(re). For example, a MEWS(re) threshold of 6 as the trigger for an alarm would identify 15% of all transfers to the ICU, with 34.4 false alarms for each transfer; in contrast, using the EMR‐based approach to identify 15% of all transfers, there were 14.5 false alarms for each transfer. Applied to the entire KPMCP Northern California Region, using the MEWS(re), a total of 52 patients per day would need to be evaluated, but only 22 per day using the EMR‐based approach. If one employed a MEWS(re) threshold of 4, this would lead to identification of 44% of all transfers, with a ratio of 69 false alarms for each transfer; using the EMR, the ratio would be 34 to 1. Across the entire KPMCP, a total of 276 patients per day (or about 19.5 a day per hospital) would need to be evaluated using the MEWS(re), but only 136 (or about 9.5 per hospital per day) using the EMR.

DISCUSSION

Using data from a large hospital cohort, we have developed a predictive model suitable for use in non‐ICU populations cared for in integrated healthcare settings with fully automated EMRs. The overall performance of our model, which incorporates acute physiology, diagnosis, and longitudinal data, is superior to the predictive ability of a model that can be assigned manually. This is not surprising, given that scoring systems such as the MEWS make an explicit tradeoff losing information found in multiple variables in exchange for ease of manual assignment. Currently, the model described in this report is being implemented in a simulated environment, a final safety test prior to piloting real‐time provision of probability estimates to clinicians and nurses. Though not yet ready for real‐time use, it is reasonable for our model to be tested using the KPHC shadow server, since evaluation in a simulated environment constitutes a critical evaluation step prior to deployment for clinical use. We also anticipate further refinement and revalidation to occur as more inpatient data become available in the KPMCP and elsewhere.

A number of limitations to our approach must be emphasized. In developing our models, we determined that, while modeling by clinical condition was important, the study outcome was rare for some primary conditions. In these diagnostic groups, which accounted for 12.5% of the event shifts and 10.6% of the comparison shifts, the c‐statistic in the validation dataset was <0.70. Since all 22 KPMCP hospitals are now online and will generate an additional 150,000 adult hospitalizations per year, we expect to be able to correct this problem prior to deployment of these models for clinical use. Having additional data will permit us to improve model discrimination and thus decrease the evaluation‐to‐detection ratio. In future iterations of these models, more experimentation with grouping of International Classification of Diseases (ICD) codes may be required. The problem of grouping ICD codes is not an easy one to resolve, in that diagnoses in the grouping must share common pathophysiology while having a grouping with a sufficient number of adverse events for stable statistical models.

Ideally, it would have been desirable to employ a more objective measure of deterioration, since the decision to transfer a patient to the ICU is discretionary. However, we have found that key data points needed to define such a measure (eg, vital signs) are not consistently charted when a patient deterioratesthis is not surprising outside the research setting, given that nurses and physicians involved in a transfer may be focusing on caring for the patient rather than immediately charting. Given the complexities of end‐of‐life‐care decision‐making, we could not employ death as the outcome of interest. A related issue is that our model does not differentiate between reasons for needing transfer to the ICU, an issue recently discussed by Bapoje et al.18

Our model does not address an important issue raised by Bapoje et al18 and Litvak, Pronovost, and others,19, 20 namely, whether a patient should have been admitted to a non‐ICU setting in the first place. Our team is currently developing a model for doing exactly this (providing decision support for triage in the emergency department), but discussion of this methodology is outside the scope of this article.

Because of resource and data limitations, our model also does not include newborns, children, women admitted for childbirth, or patients transferred from non‐KPMCP hospitals. However, the approach described here could serve as a starting point for developing models for these other populations.

The generalizability of our model must also be considered. The Northern California KPMCP is unusual in having large electronic databases that include physiologic as well as longitudinal patient data. Many hospitals cannot take advantage of all the methods described here. However, the methods we employed could be modified for use by hospital systems in countries such as Great Britain and Canada, and entities such as the Veterans Administration Hospital System in the United States. The KPMCP population, an insured population with few barriers to access, is healthier than the general population, and some population subsets are underrepresented in our cohort. Practice patterns may also vary. Nonetheless, the model described here could serve as a good starting point for future collaborative studies, and it would be possible to develop models suitable for use by stand‐alone hospitals (eg, recalibrating so that one used a Charlson comorbidity21 score based on present on‐admission codes rather than the COPS).

The need for early detection of patient deterioration has played a major role in the development of rapid response teams, as well as scores such as the MEWS. In particular, entities such as the Institute for Healthcare Improvement have advocated the use of early warning systems.22 However, having a statistically robust model to support an early warning system is only part of the solution, and a number of new challenges must then be addressed. The first is actual electronic deployment. Existing inpatient EMRs were not designed with complex calculations in mind, and we anticipate that some degradation in performance will occur when we test our models using real‐time data capture. As Bapoje et al point out, simply having an alert may be insufficient, since not all transfers are preventable.18 Early warning systems also raise ethical issues (for example, what should be done if an alert leads a clinician to confront the fact that an end‐of‐life‐care discussion needs to occur?). From a research perspective, if one were to formally test the benefits of such models, it would be critical to define outcome measures other than death (which is strongly affected by end‐of‐life‐care decisions) or ICU transfer (which is often desirable).

In conclusion, we have developed an approach for predicting impending physiologic deterioration of hospitalized adults outside the ICU. Our approach illustrates how organizations can take maximal advantage of EMRs in a manner that exceeds meaningful use specifications.23, 24 Our study highlights the possibility of using fully automated EMR data for building and applying sophisticated statistical models in settings other than the highly monitored ICU without the need for additional equipment. It also expands the universe of severity scoring to one in which probability estimates are provided in real time and throughout an entire hospitalization. Model performance will undoubtedly improve over time, as more patient data become available. Although our approach has important limitations, it is suitable for testing using real‐time data in a simulated environment. Such testing would permit identification of unanticipated problems and quantification of the degradation of model performance due to real life factors, such as delays in vital signs charting or EMR system brownouts. It could also serve as the springboard for future collaborative studies, with a broader population base, in which the EMR becomes a tool for care, not just documentation.